Intravenous Solutions Market to see Rapid Growth by 2029

Intravenous solutions market is anticipated to grow at a significant CAGR of 8.7% during the forecast period. The rising number of gastrointestinal diseases such as IBS (Irritable bowel syndrome), and others is growing the demand for intravenous solution across the globe during the forecast period. These intravenous solutions are the main sources of energy for patients going through various treatment. According to International Foundation for Functional Gastrointestinal Disorders (IFFGD), around 5-10% peoples across the globe is having IBS, most persons with IBS are under the age of 50. Gastrointestinal diseases affect the gastrointestinal (GI) tract from the mouth to the anus. Approximately 20 to 40% of all visits to gastroenterologists are due to IBS symptoms. IBS affects between 25 and 45 million people in the US. About 2 in 3 IBS sufferers are female and about 1 in 3 IBS sufferers are male. Intravenous solutions are liquids which are injected into a person’s veins through an IV (intravenous) tube. They prevent or treat dehydration and correct the electrolyte imbalances in body by providing important nutrients to the body. These intravenous solutions can help individuals with IBS by quickly getting vitamins and other nutrients into the body. The stomach and other parts of the digestive system may be sensitive to oral vitamins and experience irritation from things like magnesium or vitamin C, the intravenous solution can will help get the nutrients into your bloodstream and cells without having to enter the digestive tract and potentially upsetting the stomach. These factors supports the growth of the intravenous solutions during the forecast period as they are majorly used during various treatment. 

The global intravenous solutions market is segmented based on product and nutrients. Based on the product, the market is segmented into total parenteral nutrition, and peripheral parenteral nutrition. Based on nutrients, the market is sub-segmented into carbohydrates, vitamins and minerals, single dose amino acids, parenteral lipid emulsion, others. The above mentioned segments can be customized as per the requirements. Based on product the total parenteral nutrition (TPN) segment is anticipated to grow at the fastest rate during the forecast period owing to the increasing number of old-age population across the globe. Many of the old-age patients are unable to absorb essential nutrients and thus, these essential nutrients are delivered through an intravenous solution directly in the body. According to UN world population ageing data, there were around 727 million persons aged 65 years or over in 2020 and it is expected to reach around 1.5 billion by 2050. Across the globe,the share of the population aged 65 years or over is expected to increase from 9.3% in 2020 to around 16.0% in 2050. Hence, this increasing aging population will boost total parenteral nutrition (TPN) segment as old-age patients require the feeding of essential nutrients through intravenous routes in the form of intravenous solutions.

To Request a Sample of our Report on Intravenous Solutions Market:  https://www.omrglobal.com/request-sample/intravenous-solutions-market

Intravenous Solutions Market Segmentation

By Product

·        Total Parenteral Nutrition

·        Peripheral Parenteral Nutrition

By Nutrients

·        Carbohydrates

·        Vitamins and Minerals

·        Single Dose Amino Acids

·        Parenteral Lipid Emulsion

·        Others

A full Report of Intravenous Solutions Market is Available @  https://www.omrglobal.com/industry-reports/intravenous-solutions-market

Regional Analysis                                                                                                                                                                            

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

Company Profiles 

·        Amanta Healthcare Ltd.

·        Anhui Medipharm Co. Ltd

·        Axa Parenterals Ltd.

·        Fresenius Kabi AG

·        JW Group corp.

·        Omnicare, Inc.

·        Otsuka Pharmaceutical Co., Ltd.

·        Salius Pharma Private Ltd.

·        Vifor Pharma Management Ltd.

·        Wuhan Uni-Pharma Bio-Tech Co. Ltd

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/intravenous-solutions-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404